Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
7.91
-0.03 (-0.38%)
At close: May 13, 2025, 4:00 PM
7.85
-0.06 (-0.76%)
After-hours: May 13, 2025, 7:25 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Biotechnology
14.02M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
14.02M